Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Sirona Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Sirona Capital

Sirona Capital

Operating

Sirona Capital: A real estate firm specializing in property investment, development, and urban renewal.

Location
West Perth, Western Australia, AU
Founded
2010
Firm
Compare
Portfolio
Employees

Sirona Capital is a versatile investment firm focusing on both real estate and life sciences sectors. In real estate, they specialize in property investment, development, and urban renewal projects. Their life sciences portfolio spans various stages, from seed to Series D rounds, with investments typically ranging from $9.5 million to $121 million.

Notable portfolio companies include Adarx Pharmaceuticals, Antiva Biosciences, and Arvinas. Sirona Capital's diverse investment approach demonstrates their commitment to supporting innovative companies across different growth stages. Their involvement in both real estate and biotechnology sectors suggests a strategy aimed at balancing stable assets with high-growth potential investments.

Sirona Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments8
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Series C3 (37.5%)
Series B2 (25.0%)
Seed1 (12.5%)
Series A1 (12.5%)
Series D1 (12.5%)

Stage Mix

Series C 38%Series B 25%Seed 13%Series A 13%Series D 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Synnovation Therapeutics logo

Synnovation Therapeutics

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

Fuse Biotherapeutics logo

Fuse Biotherapeutics

Antiva Biosciences logo

Antiva Biosciences

Arvinas logo

Arvinas

Hookipa Pharma logo

Hookipa Pharma

Sirona Capital - Similar Investment Firms

Sorin Investments logo

Sorin Investments

Xeraya Capital logo

Xeraya Capital

xeraya.com

Apeiron Investment Group logo

Apeiron Investment Group

Sitka Partners logo

Sitka Partners

sitkapartners.com

Siana Capital Management logo

Siana Capital Management

sianacapital.com

Siar Capital logo

Siar Capital

SRI Capital logo

SRI Capital

sricapital.com

Grupo Sierra Capital logo

Grupo Sierra Capital

SilverArc Capital logo

SilverArc Capital

Luminor Capital logo

Luminor Capital

Sr One logo

Sr One

srone.com

Samsara BioCapital logo

Samsara BioCapital

samsaracap.com

Biospring Partners logo

Biospring Partners

biospring.com

Advent Life Sciences logo

Advent Life Sciences

adventls.com

Sovereign's Capital logo

Sovereign's Capital

Sirona Capital - Classification

Also Known As
  • Sirona Capital Pte. Ltd.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified